After years of anticipation, California Gov. Gavin Newsom said the state would contract with Civica, a Utah-based generic pharmaceutical company, to start producing California-branded insulin, available for $30 for a 10 mL vial. Once the Food and Drug Administration approves the new insulin, Civica can begin manufacturing. Reporter Rachel Bluth talks with host Ben Leonard about about the deal.

Learn more about your ad choices. Visit megaphone.fm/adchoices